NCT07201402

Long Term Evaluation of Scapular-inserted Contraceptive Implants

Prospective Long-term Study of Etonogestrel Contraceptive Implant Insertion at an Alternative Scapular Site

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 62 (estimated)
• Sponsor: Yale University · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive implant inserted at this alternative scapular site over the course of at least two years.

Conditions

• Contraception

Interventions

Type	Name	Description
DRUG	Scapular-site insertion of etonogestrel contraceptive implant	Participants will undergo insertion of the etonogestrel contraceptive implant subdermally over the inferior edge of their non-dominant scapula

Timeline

• Start date: 2026-03-15
• Primary completion: 2027-10-01
• Completion: 2027-10-01
• First posted: 2025-10-01
• Last updated: 2026-04-14

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated drug study